AAAAAA

   
Results: 1-10 |
Results: 10
PHASE-I TRIAL OF A HUMAN-MOUSE CHIMERIC ANTI-DISIALOGANGLIOSIDE MONOCLONAL-ANTIBODY CH14.18 IN PATIENTS WITH REFRACTORY NEUROBLASTOMA AND OSTEOSARCOMA
Authors: YU AL UTTENREUTHERFISCHER MM HUANG CS TSUI CC GILLIES SD REISFELD RA KUNG FH
Citation: Al. Yu et al., PHASE-I TRIAL OF A HUMAN-MOUSE CHIMERIC ANTI-DISIALOGANGLIOSIDE MONOCLONAL-ANTIBODY CH14.18 IN PATIENTS WITH REFRACTORY NEUROBLASTOMA AND OSTEOSARCOMA, Journal of clinical oncology, 16(6), 1998, pp. 2169-2180
DISTRIBUTION OF RADIOLABELED ANTI-CA125 MONOCLONAL-ANTIBODY OC125-F(AB')(2)-FRAGMENT FOLLOWING RESECTION GUIDED BY ANTIBODIES (REGAJ) IN OVARIAN-CANCER PATIENTS
Authors: UTTENREUTHERFISCHER MM FEISTEL H WOLF F JAGER W
Citation: Mm. Uttenreutherfischer et al., DISTRIBUTION OF RADIOLABELED ANTI-CA125 MONOCLONAL-ANTIBODY OC125-F(AB')(2)-FRAGMENT FOLLOWING RESECTION GUIDED BY ANTIBODIES (REGAJ) IN OVARIAN-CANCER PATIENTS, Journal of clinical laboratory analysis, 11(2), 1997, pp. 94-103
PEDIATRIC THROMBOEMBOLISM - THE INFLUENCE OF NONGENETIC FACTORS AND THE ROLE OF ACTIVATED PROTEIN-C RESISTANCE AND PROTEIN-C DEFICIENCY
Authors: UTTENREUTHERFISCHER MM VETTER B HELLMANN C OTTING U ZIEMER S HAUSDORF G GAEDICKE G KULOZIK AE
Citation: Mm. Uttenreutherfischer et al., PEDIATRIC THROMBOEMBOLISM - THE INFLUENCE OF NONGENETIC FACTORS AND THE ROLE OF ACTIVATED PROTEIN-C RESISTANCE AND PROTEIN-C DEFICIENCY, European journal of pediatrics, 156(4), 1997, pp. 277-281
MONOCLONAL IGG ANTIPLATELET AUTOANTIBODIES FROM 3 PATIENTS WITH ITP DERIVED BY PHAGE DISPLAY AND PANNING ON THERAPEUTIC IMMUNOGLOBULINS
Authors: FISCHER P JENDREYKO N UTTENREUTHERFISCHER MM GAEDICKE G
Citation: P. Fischer et al., MONOCLONAL IGG ANTIPLATELET AUTOANTIBODIES FROM 3 PATIENTS WITH ITP DERIVED BY PHAGE DISPLAY AND PANNING ON THERAPEUTIC IMMUNOGLOBULINS, Blood, 90(10), 1997, pp. 1796-1796
PHAGE DISPLAY DERIVED IGG ANTIBODIES SELECTED WITH THERAPEUTIC IMMUNOGLOBULINS FROM A PATIENT WITH AIHA AND TRANSIENT ITP SHARE SEQUENCE HOMOLOGY WITH KNOWN ANTI-RHD AND ANTIPLATELET ANTIBODIES
Authors: JENDREYKO N UTTENREUTHERFISCHER MM GAEDICKE G FISCHER P
Citation: N. Jendreyko et al., PHAGE DISPLAY DERIVED IGG ANTIBODIES SELECTED WITH THERAPEUTIC IMMUNOGLOBULINS FROM A PATIENT WITH AIHA AND TRANSIENT ITP SHARE SEQUENCE HOMOLOGY WITH KNOWN ANTI-RHD AND ANTIPLATELET ANTIBODIES, Blood, 90(10), 1997, pp. 2042-2042
KAWASAKI-DISEASE - UPDATE ON DIAGNOSIS, TREATMENT, AND A STILL CONTROVERSIAL ETIOLOGY
Authors: FISCHER P UTTENREUTHERFISCHER MM NAOE S GAEDICKE G
Citation: P. Fischer et al., KAWASAKI-DISEASE - UPDATE ON DIAGNOSIS, TREATMENT, AND A STILL CONTROVERSIAL ETIOLOGY, Pediatric hematology and oncology, 13(6), 1996, pp. 487-501
RESISTANCE TO ACTIVATED PROTEIN-C (APCR) - REFERENCE VALUES OF APC-RATIOS FOR CHILDREN
Authors: UTTENREUTHERFISCHER MM ZIEMER S GAEDICKE G
Citation: Mm. Uttenreutherfischer et al., RESISTANCE TO ACTIVATED PROTEIN-C (APCR) - REFERENCE VALUES OF APC-RATIOS FOR CHILDREN, Thrombosis and haemostasis, 76(5), 1996, pp. 813-814
SUPERANTIGENS IN THE ETIOLOGY OF KAWASAKI-DISEASE
Authors: FISCHER P UTTENREUTHERFISCHER MM GAEDICKE G
Citation: P. Fischer et al., SUPERANTIGENS IN THE ETIOLOGY OF KAWASAKI-DISEASE, Lancet, 348(9021), 1996, pp. 202-202
PHARMACOKINETICS OF HUMAN-MOUSE CHIMERIC ANTI-GD2 MAB CH14.18 IN A PHASE-I TRIAL IN NEUROBLASTOMA PATIENTS
Authors: UTTENREUTHERFISCHER MM HUANG CS YU AL
Citation: Mm. Uttenreutherfischer et al., PHARMACOKINETICS OF HUMAN-MOUSE CHIMERIC ANTI-GD2 MAB CH14.18 IN A PHASE-I TRIAL IN NEUROBLASTOMA PATIENTS, Cancer immunology and immunotherapy, 41(6), 1995, pp. 331-338
PHARMACOKINETICS OF ANTIGANGLIOSIDE GD2 MAB 14G2A IN A PHASE-I TRIAL IN PEDIATRIC CANCER-PATIENTS
Authors: UTTENREUTHERFISCHER MM HUANG CS REISFELD RA YU AL
Citation: Mm. Uttenreutherfischer et al., PHARMACOKINETICS OF ANTIGANGLIOSIDE GD2 MAB 14G2A IN A PHASE-I TRIAL IN PEDIATRIC CANCER-PATIENTS, Cancer immunology and immunotherapy, 41(1), 1995, pp. 29-36
Risultati: 1-10 |